Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:59:46.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an improvement in the percentage of BCNS patients who achieve disease control at 18 months from 50% to 80% through the combined inhibition of SMO and PD-1.
    Difference
    0.1%
    Check dated 2024-06-06T14:30:25.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying requirements such as having 10 or more surgically eligible BCCs within the prior 2 years, being over 16 years old, and having a Karnofsky Performance Score (KPS) greater than 60%. Previously, no information was provided about the participation criteria.
    Difference
    31%
    Check dated 2024-05-22T21:13:10.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T21:56:00.000Z thumbnail image

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.